Sorterad på relevans Sortera på datum
Resultat 1 - 4 av 4

Crunchfish publishes interim report Q1 2024

Today, Crunchfish AB (“Crunchfish”) publishes the company’s interim report for the first quarter of 2024. Below is a brief summary of the report.

Sammanhang: ...Today, Crunchfish AB (“Crunchfish”) publishes the company’s interim report for the first quarter of 2024. Below is a brief summary of the report....

di.se - https://www.di.se/pr...t-q1-2024/ - 145 - Datum: 2024-05-21 09:17. - Leta efter artikeln på Archive.today »

The 77-Year-Old Construction Tycoon Who Built Soccer’s Greatest Dynasty

To some, Real Madrid president Florentino Pérez is a soccer visionary. To others, he’s a Bond villain. What’s indisputable is his record as one of the most successful executives in sports history.

Sammanhang: ...To some, Real Madrid president Florentino Pérez is a soccer visionary. To others, he’s a Bond villain. What’s indisputable is his record as one of the most successful executives in sports history....

Omnämnda personer: Florentino Pérez, Real Madrid.

di.se - https://www.di.se/ny...t-dynasty/ - 196 - Datum: 2024-05-30 23:16. - Leta efter artikeln på Archive.today »

DFDS Elevates Passenger Experience with NowhereConnect Suite

DFDS, a leader in maritime transportation, has entered a strategic deal with Nowhere Networks to deploy the innovative NowhereConnect Suite on its fleet of six ships operating on the English Channel. This collaboration is a milestone in enhancing passengers’

Sammanhang: ...DFDS, a leader in maritime transportation, has entered a strategic deal with Nowhere Networks to deploy the innovative NowhereConnect Suite on its fleet of six ships operating on the English Channel. This collaboration is a milestone in enhancing passengers’ experience of connectivity, as well as optimizing bandwidth....

di.se - https://www.di.se/pr...ect-suite/ - 319 - Datum: 2023-12-20 09:17. - Leta efter artikeln på Archive.today »

Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients

Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian

Sammanhang: ...The Phase 2 trial is a randomized controlled study designed to assess progression-free survival (PFS) in primary advanced ovarian cancer patients treated with Radspherin® following complete surgical resection and pre-operative chemotherapy....

Omnämnda personer: with Radspherin.

di.se - https://www.di.se/pr...spherin-r/ - 646 - Datum: 2024-10-10 11:16. - Leta efter artikeln på Archive.today »